# Tharos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tharos

- Industry: Food
- Headquarters: London, UK
- Website: www.tharos.co.uk
- Total disclosed funding: $0.5M
- Latest round: Seed (Feb 8, 2019)
- Investors on record: 1

## About

Tharos Ltd. is a UK-based company dedicated to enhancing animal microbiome health through specialized nutritional products, focusing on equine and canine markets.Founded in 2015 in London, UK, Tharos Ltd. specializes in animal health products. The company was co-founded by Douglas Dundonald and Rosemary Waring. In February 2019, Tharos Ltd. secured GBP 0.4 million in SEED funding from Cross Border Angels, amounting to the total funds raised. The company has conducted a single deal to date, reflecting its growth trajectory in the niche market of animal health.Tharos Ltd specializes in innovative products aimed at enhancing animal microbiome health, focusing on equine and canine nutrition. Their flagship products include EquiNectar, designed to improve gut health in horses, and CaniNectar, which supports digestive wellbeing in dogs. These products utilize unique formulations targeting the animal microbiome, addressing digestive health and vitality. Tharos Ltd. caters to a diverse clientele, including individual pet owners and equestrian professionals throughout the UK and select European markets, emphasizing sustainability and effectiveness in their offerings.Tharos Ltd generates revenue through direct-to-consumer sales and partnerships with retailers distributing their specialized animal health products. Customers typically purchase products like EquiNectar and CaniNectar via the company’s online platform or authorized retailers. The pricing structure reflects the premium positioning of these products, serving pet owners and equestrian specialists who prioritize animal health and wellness. By maintaining a straightforward retail model, Tharos Ltd. enhances accessibility for consumers and partners, fostering strong relationships and driving sales.Tharos Ltd. plans to leverage its recent SEED funding of GBP 0.4 million obtained in February 2019 to advance its product development and market presence. The company is working on new product formulations aimed at further enhancing animal health, although specific launch dates have not been disclosed. Additionally, Tharos Ltd. intends to expand into selected markets across Europe, targeting broader distribution channels to reach a wider customer base. These initiatives demonstrate the company's strategic focus on growth and commitment to improving animal health.

## Funding rounds

- Seed, Feb 8, 2019, $0.5M — Cross Border Angels

## Investors

- Cross Border Angels (https://capitalatlas.ai/funds/cross-border-angels) — Seed